Trevena, Inc. (NASDAQ:TRVN – Get Free Report) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.01 and traded as high as $0.0111. Trevena shares last traded at $0.0111, with a volume of 965 shares.
Trevena Trading Up 1,000.0%
The company has a market cap of $10,549.00, a price-to-earnings ratio of 0.00 and a beta of 0.30. The business’s 50 day moving average price is $0.01 and its 200-day moving average price is $0.01.
About Trevena
Trevena, Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of biased ligand G protein-coupled receptor (GPCR) selective medicines. By leveraging its proprietary bias-ligand technology platform, Trevena aims to create therapies that preferentially activate beneficial signaling pathways while minimizing engagement of pathways linked to adverse effects. The company’s research efforts target areas of high unmet medical need, including pain management, cardiometabolic disorders and central nervous system conditions.
The company’s lead compound, oliceridine (also known by its brand name OLINVEO), is a G protein-biased μ-opioid receptor agonist designed for the treatment of moderate to severe acute pain in the hospital setting.
Recommended Stories
- Five stocks we like better than Trevena
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Receive News & Ratings for Trevena Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trevena and related companies with MarketBeat.com's FREE daily email newsletter.
